SCHEMBL17065828

SCHEMBL17065828

CCN(CC)c1c(Br)ccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TSHR P16473 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP2A6 P11509 2/20 0.39
HSD17B10 Q99714 1/20 0.39
ELANE P08246 1/20 0.38
POLB P06746 1/20 0.37
HPGD P15428 1/20 0.37
HPRT1 P00492 1/20 0.37
CYP1A2 P05177 3/20 0.36
CYP2D6 P10635 2/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
ACP1 P24666 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14283527 0.79 CYP1A2 (0.50) NPC1RAB9ATSHRTDP1ALDH1A1
SCHEMBL8584659 0.79 CYP2A6 (0.41) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL23457936 0.78 ELANE (0.41) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL29862150 0.78 ELANE (0.41) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL11347674 0.76 L3MBTL1 (0.43) TSHRALDH1A1CYP2A6HSD17B10ELANE
SCHEMBL29862563 0.75 CYP1A2 (0.38) MAPTNPC1TSHRTDP1ALDH1A1
SCHEMBL23457995 0.75 SMN1; SMN2 (0.38) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL23458213 0.75 CYP1A2 (0.38) MAPTNPC1TSHRTDP1ALDH1A1
SCHEMBL2203473 0.74 NPC1 (0.48) MAPTNPC1RAB9ASMN1; SMN2TSHR
SCHEMBL17065837 0.74 CRHR1 (0.42) MAPTNPC1RAB9ATDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113768-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS Universita' Degli Studi Di Pavia (IT) 2017-01-11 EP disclosed
WO-2015132733-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS UNIVERSITA' DEGLI STUDI DI PAVIA (IT) 2015-09-11 WO disclosed